Dumadaug, Eriberto F.

HRN: 21-56-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2025
CEFTAZIDIME 1GM (VIAL)
01/20/2025
01/27/2025
IV
1g
Q8
DM FOOT
Waiting Final Action 
01/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/20/2025
01/27/2025
IVTT
300
Q6
DM FOOT
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: